These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37918578)

  • 1. Genetic variations in a Sestrin2/Sestrin3/mTOR Axis and development of new-onset diabetes after kidney transplantation.
    Luu D; Shah T; Sakharkar P; Min DI
    Transpl Immunol; 2023 Dec; 81():101947. PubMed ID: 37918578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of the transcription factor NFATc4 and development of new-onset diabetes after transplantation in Hispanic kidney transplant recipients.
    Chen Y; Sampaio MS; Yang JW; Min D; Hutchinson IV
    Transplantation; 2012 Feb; 93(3):325-30. PubMed ID: 22234350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L; Sombogaard F; Hesselink DA; van Schaik RH; van Gelder T
    Pharmacogenet Genomics; 2013 Dec; 23(12):649-57. PubMed ID: 24113216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.
    Chakkera HA; Hanson RL; Raza SM; DiStefano JK; Millis MP; Heilman RL; Mulligan DC; Reddy KS; Mazur MJ; Hamawi K; Moss AA; Mekeel KL; Cerhan JR
    Transplant Proc; 2009 Dec; 41(10):4172-7. PubMed ID: 20005362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between 276G/T adiponectin gene polymorphism and new-onset diabetes after kidney transplantation.
    Nicoletto BB; Souza GC; Fonseca NK; Centenaro A; Manfro RC; Canani LH; Gonçalves LF
    Transplantation; 2013 Dec; 96(12):1059-64. PubMed ID: 23985723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation.
    Parvizi Z; Azarpira N; Kohan L; Darai M; Kazemi K; Parvizi MM
    Mol Biol Rep; 2014 Sep; 41(9):6063-9. PubMed ID: 24996284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.
    Kurzawski M; Dziewanowski K; Łapczuk J; Wajda A; Droździk M
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1587-94. PubMed ID: 22569928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 receptor antagonists: Protective factors against new-onset diabetes after renal transplantation.
    Xue M; Zhao C; Lv C; Chen M; Xu M; Rong R; Zhang Y; Liang J; Gao J; Yu M; Zhu T; Gao X
    J Diabetes; 2018 Nov; 10(11):857-865. PubMed ID: 29577632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive therapy as a risk factor for new-onset diabetes after transplantation].
    Allazova SS; Novikova MS; Kotenko ON; Shilov EM
    Ter Arkh; 2020 Dec; 92(12):137-141. PubMed ID: 33720585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of single nucleotide polymorphisms implicate mTOR signalling in the development of new-onset diabetes after transplantation.
    Chand S; McKnight AJ; Shabir S; Chan W; McCaughan JA; Maxwell AP; Harper L; Borrows R
    BBA Clin; 2016 Jun; 5():41-5. PubMed ID: 27051588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ADIPOQ gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation.
    Cen C; Fang HX; Yu SF; Liu JM; Liu YX; Zhou L; Yu J; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):602-609. PubMed ID: 29291779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for development of new-onset diabetes after kidney transplantation.
    Bee YM; Tan HC; Tay TL; Kee TY; Goh SY; Kek PC
    Ann Acad Med Singap; 2011 Apr; 40(4):160-7. PubMed ID: 21678001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinase Gene Polymorphisms and New-Onset Diabetes After Kidney Transplantation in Korean Renal Transplant Subjects.
    Ong S; Kang SW; Kim YH; Kim TH; Jeong KH; Kim SK; Yoon YC; Seo SK; Moon JY; Lee SH; Ihm CG; Lee TW; Chung JH
    Transplant Proc; 2016 Apr; 48(3):858-63. PubMed ID: 27234753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors of New-onset Diabetes After Renal Transplantation and Prognostic Analysis.
    Wang Q; Wu J; Wang X; Huang Y; Li G; Ou T
    Altern Ther Health Med; 2023 Mar; 29(2):230-235. PubMed ID: 36525355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation.
    Kim YG; Ihm CG; Lee TW; Lee SH; Jeong KH; Moon JY; Chung JH; Kim SK; Kim YH
    Transplantation; 2012 May; 93(9):900-7. PubMed ID: 22377791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.
    Shi D; Xie T; Deng J; Niu P; Wu W
    Eur J Clin Pharmacol; 2018 Jun; 74(6):723-729. PubMed ID: 29546446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients.
    Eisenga MF; Zelle DM; Sloan JH; Gaillard CAJM; Bakker SJL; Dullaart RPF
    Diabetes Care; 2017 Jul; 40(7):894-901. PubMed ID: 28461454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A.
    Ergün I; Keven K; Sengül S; Karabulut HG; Kurultak I; Soypacaci Z; Erbay B
    Int Urol Nephrol; 2011 Jun; 43(2):543-8. PubMed ID: 20559724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.